HomeCompaniesProfile

Indee Labs

Enabling T cell immunotherapy discovery, development and manufacturing 


Company Size

1 - 5 employees

Year Founded

2015


About Indee Labs

Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.

Founders & Key People

Ryan Pawell

Ryan Pawell

Founder/CEO, Indee Labs

Share This Profile

More Companies

Shipamax

Simple, end-to-end automation for logistics orgs

Daedalus

AWS for precision manufacturing

Mono

Embedded finance infrastructure for LatAm enterprises.

ZeroDown

Find beautiful homes

Turing Labs Inc.

AI for R&D of consumer brands like P&G to develop better products

June

June is the new way to do product analytics

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2026 BEAMSTART. All Rights Reserved.